Dear Colleague,

The FierceBiotech Drug Development Forum, (Oct. 1–3, Boston) brings together 100+ biotech speakers – nearly all at the C-suite or VP level – to discuss the greatest challenges and breakthroughs that FierceBiotech has covered all year long!

Don’t miss out on these in-depth sessions on business strategy and drug development:

PURSUE BREAKTHROUGH APPROVALS IN MULTIPLE GLOBAL MARKETS

• Julian Adams, CEO, GAMIDA CELL
• Roy Baynes, CMO, Senior Vice President, Clinical Development, MERCK
• Maria Fardis, CEO, IOVANCE
• Amrit Ray, Global President, R&D, PFIZER ESSENTIAL HEALTH
• Martine Zimmerman, Senior Vice President, Global Regulatory Affairs, ALEXION PHARMACEUTICALS

Recognize when Novel Technologies can Disrupt Standard Business Development

• Dolores Baksh, Innovation Leader, GE HEALTHCARE
• Steven Holtzman, CEO, DECIBEL THERAPEUTICS
• Nouhad Husseini, Vice President, Head of Business Development, REGENERON
• Kim Seth, Executive Vice President, Head of Business and Corporate Development, REPARE THERAPEUTICS
• Praveen Tipirneni, CEO, MORPHIC THERAPEUTICS

Improve Orphan Drug Strategy so Your Company can Grow Up with Your Patients

• Holly May, Vice President, Sales and Marketing, SOBI
• Amit Rakhit, CMO, OVID THERAPEUTICS

Meet and Beat Ambitious Growth Plans to Surpass Investor Expectations

• Jonathan Garen, CBO, UNIQURE
• Luca Santarelli, CEO, THERACHON
• Dan Wechsler, CEO, MELINTA THERAPEUTICS